Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 5 M2 M4 M8 M 19 M Research & development ———— — Operating income 51 M-488 M32 M30 M -375 M Non-Operating Income, Total -10 M-9 M-11 M-4 M -34 M Interest expense, net of interest capitalized 12 M12 M11 M8 M 43 M Non-Operating Income, excl. Interest Expenses -12 M-12 M-11 M-8 M -43 M Unusual income/expense 2 M3 M04 M 9 M Pretax income 41 M-497 M21 M26 M -409 M Equity in earnings ———— — Taxes 14 M-110 M5 M8 M -83 M Non-controlling/minority interest ———— — After tax other income/expense 1 M1 M1 M1 M 4 M Net income before discontinued operations 27 M-387 M16 M18 M -326 M Discontinued operations ———— — Net income 27 M-387 M16 M18 M -326 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 27 M-387 M16 M18 M -326 M Basic earnings per share (Basic EPS) 1-13.341.240.45 -10.65 Diluted earnings per share (Diluted EPS) 1-13.341.240.45 -10.65 Average basic shares outstanding —29 M26.31 M26.31 M — Diluted shares outstanding —29 M26.31 M26.31 M — EBITDA 103 M-435 M86 M82 M -164 M EBIT 51 M-488 M32 M30 M -375 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 52 M53 M54 M52 M 211 M